Literature DB >> 12496511

Rheumatic syndromes associated with complement deficiency.

Maria-Louise Barilla-LaBarca1, John P Atkinson.   

Abstract

Deficiency of an early component of the classical complement pathway, C1q, C1r/C1s, C4, or C2, regularly produces autoimmunity in man, especially systemic lupus erythematosus. It has long been suggested that disruption of this pathway would lead to the inappropriate handling of immune complexes. An intriguing hypothesis that builds on this idea relates to a defect in clearance of one's own cellular debris, namely apoptotic cells. An attractive feature of this emerging concept is that blebs on apoptotic cells are decorated with antigens to which much of the autoantibody specificity is directed in systemic lupus erythematosus. A second hypothesis, generated primarily from complement deficiencies, relates to an impairment in the humoral immune response or in the regulation of autoreactive B cells. This review begins by summarizing the recognized autoimmune manifestations of complement deficiency and then describes new data derived from targeted gene deletions of complement proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12496511     DOI: 10.1097/00002281-200301000-00010

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  18 in total

1.  Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice.

Authors:  Julia Menke; Tillmann Bork; Birte Kutska; Katelyn T Byrne; Michaela Blanfeld; Manfred Relle; Vicki R Kelley; Andreas Schwarting
Journal:  Kidney Int       Date:  2010-10-27       Impact factor: 10.612

2.  A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM.

Authors:  Haoyang Zhuang; Shuhong Han; Yi Li; Deborah Kienhöfer; Pui Lee; Stepan Shumyak; Richard Meyerholz; Krzysztof Rosadzinski; Danielle Rosner; Annie Chan; Yuan Xu; Mark Segal; Eric Sobel; Li-Jun Yang; Markus H Hoffmann; Westley H Reeves
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

Review 3.  Antibodies against C1q in patients with systemic lupus erythematosus.

Authors:  Marten Trendelenburg
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

4.  Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China.

Authors:  Cai-Qin Zhang; Lei Ren; Fei Gao; Feng-Yun Mu; Yan-Qiu You; Yan-Hong Liu
Journal:  Clin Rheumatol       Date:  2011-02-23       Impact factor: 2.980

Review 5.  Tolerance and autoimmunity in primary immunodeficiency disease: a comprehensive review.

Authors:  Sudhir Gupta; Ankmalika Gupta Louis
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 6.  [Systemic lupus erythematosus-are children small adults?]

Authors:  Tobias Alexander; Christian M Hedrich
Journal:  Z Rheumatol       Date:  2021-11-08       Impact factor: 1.372

Review 7.  New advances in measurement of complement activation: lessons of systemic lupus erythematosus.

Authors:  Chau-Ching Liu; Susan Manzi; Natalya Danchenko; Joseph M Ahearn
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

Review 8.  Current advances in the human lupus genetics.

Authors:  Nan Shen; Betty P Tsao
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

Review 9.  Autoimmunity and Immune Dysregulation in Primary Immune Deficiency Disorders.

Authors:  Heather K Lehman
Journal:  Curr Allergy Asthma Rep       Date:  2015-09       Impact factor: 4.806

10.  Anti-C1q in systemic lupus erythematosus.

Authors:  G Stojan; M Petri
Journal:  Lupus       Date:  2016-07       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.